3- (2- oxo- 3- (3- (5,6,7,8- tetrahydro- 1,8- naphthyridin- 2- yl)propyl)pyrrolidin- 1- yl)- 3- quinolin- 3- ylpropanoic acid
structure in first source
Also Known As:
(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)pyrrolidin-1-yl)-3-quinolin-3-ylpropanoic acid; (3S)-3-((3R) -2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)pyrrolidin-1-yl)-3-quinolin-3-ylpropanoic acid; (3S)-3-((3R)-2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)pyrrolidin-1-yl)-3-quinolin-3-ylpropanoic acid; (3S)-3-((3S) -2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)pyrrolidin-1-yl)-3-quinolin-3-ylpropanoic acid; (3S)-3-((3S)-2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)pyrrolidin-1-yl)-3-quinolin-3-ylpropanoic acid; 3-2-O-TN-PP-QPA; 3-OTNPPQP cpd
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results